AbbVie reports positive topline from Phase 3 CERVINO trial
AbbVie says Phase 3 CERVINO TOPLINE results are positive, with etentamig showing improved response rate and progression-free survival in relapsed/refractory multiple myeloma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.